glp 1 compounding ban New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounded GLP-1 Treatment

Moreover, the SURMOUNTMMO (tirzepatide, NCT05556512) will assess the impact of the dual GLP-1/GIP RA in cardiovascular outcomes and all-cause mortality for people with obesity (without diabetes) when the REDEFINE-3 study will assess the impact of cagrisema in people with obesity (with and without T2DM) and established cardiovascular disease

doi: 10.1016/j.ejphar.2016.04.052 72 HunterKHlscherC

Approved GLP-RAs In 2005, Exendin-4 (Exenatide/ BYETTA), the world's first GLP-1RA, was approved by the FDA for the adjuvant treatment of type 2 diabetes with two injections per day (BID)

GLP-1 is secreted by L-cells located primarily in the lower small intestine and colon, explains Patricia Bannan, RDN, a registered dietitian in Los Angeles, California

Patients within 612 months of surgery may have active gut remodeling

Mayo Clinic News Network